APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lisdexamfetamine Dimesylate Generics

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Lisdexamfetamine Dimesylate Generics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025195 pages

Choose your research edition.

Industry ResearchLisdexamfetamine Dimesylate Generics Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Lisdexamfetamine Dimesylate Generics Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Lisdexamfetamine Dimesylate Generics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lisdexamfetamine Dimesylate Generics Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Lisdexamfetamine Dimesylate Generics Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Lisdexamfetamine Dimesylate Generics market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Lisdexamfetamine Dimesylate Generics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Lisdexamfetamine Dimesylate Generics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lisdexamfetamine Dimesylate Generics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Lisdexamfetamine Dimesylate Generics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Lisdexamfetamine Dimesylate Generics include Zhejiang Huahai Pharmaceutical, Teva Pharmaceutical, Sandoz, Mylan, Sun Pharmaceutical Industries Ltd, Mallinckrodt PLC, Lannett, Hikma Pharmaceuticals and Ascent Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Lisdexamfetamine Dimesylate Generics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Lisdexamfetamine Dimesylate Generics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Lisdexamfetamine Dimesylate Generics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Lisdexamfetamine Dimesylate Generics market size, projected growth trends, production technologies, key applications, and end-use industries.

Lisdexamfetamine Dimesylate Generics Segment by Company

Zhejiang Huahai Pharmaceutical

Teva Pharmaceutical

Sandoz

Mylan

Sun Pharmaceutical Industries Ltd

Mallinckrodt PLC

Lannett

Hikma Pharmaceuticals

Ascent Pharmaceuticals

Apotex

Amneal Pharmaceuticals

Alkem Laboratories

Lisdexamfetamine Dimesylate Generics Segment by Type

Capsules

Chewable Tablets

Lisdexamfetamine Dimesylate Generics Segment by Application

Attention Deficit Hyperactivity Disorder(ADHD)

Bulimia

Other

Lisdexamfetamine Dimesylate Generics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lisdexamfetamine Dimesylate Generics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lisdexamfetamine Dimesylate Generics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lisdexamfetamine Dimesylate Generics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Lisdexamfetamine Dimesylate Generics market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Lisdexamfetamine Dimesylate Generics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Lisdexamfetamine Dimesylate Generics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Lisdexamfetamine Dimesylate Generics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Lisdexamfetamine Dimesylate Generics Industry Trends Table 2. Lisdexamfetamine Dimesylate Generics Industry Drivers Table 3. Lisdexamfetamine Dimesylate Generics Industry Opportunities and Challenges Table 4. Lisdexamfetamine Dimesylate Generics Industry Restraints Table 5. Global Lisdexamfetamine Dimesylate Generics Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Lisdexamfetamine Dimesylate Generics Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Lisdexamfetamine Dimesylate Generics Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Lisdexamfetamine Dimesylate Generics Sales Market Share by Manufacturers Table 9. Global Lisdexamfetamine Dimesylate Generics Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Lisdexamfetamine Dimesylate Generics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Lisdexamfetamine Dimesylate Generics Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Lisdexamfetamine Dimesylate Generics Manufacturers, Product Type & Application Table 13. Global Lisdexamfetamine Dimesylate Generics Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Lisdexamfetamine Dimesylate Generics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Capsules Table 17. Major Manufacturers of Chewable Tablets Table 18. Global Lisdexamfetamine Dimesylate Generics Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Lisdexamfetamine Dimesylate Generics Sales by Type (2021-2026) & (K Units) Table 20. Global Lisdexamfetamine Dimesylate Generics Sales by Type (2027-2032) & (K Units) Table 21. Global Lisdexamfetamine Dimesylate Generics Sales Market Share by Type (2021-2026) Table 22. Global Lisdexamfetamine Dimesylate Generics Sales Market Share by Type (2027-2032) Table 23. Global Lisdexamfetamine Dimesylate Generics Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Lisdexamfetamine Dimesylate Generics Revenue by Type (2021-2026) & (K Units) Table 25. Global Lisdexamfetamine Dimesylate Generics Revenue by Type (2027-2032) & (K Units) Table 26. Global Lisdexamfetamine Dimesylate Generics Revenue Market Share by Type (2021-2026) Table 27. Global Lisdexamfetamine Dimesylate Generics Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Attention Deficit Hyperactivity Disorder(ADHD) Table 29. Major Manufacturers of Bulimia Table 30. Major Manufacturers of Other Table 31. Global Lisdexamfetamine Dimesylate Generics Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Lisdexamfetamine Dimesylate Generics Sales by Application (2021-2026) & (K Units) Table 33. Global Lisdexamfetamine Dimesylate Generics Sales by Application (2027-2032) & (K Units) Table 34. Global Lisdexamfetamine Dimesylate Generics Sales Market Share by Application (2021-2026) Table 35. Global Lisdexamfetamine Dimesylate Generics Sales Market Share by Application (2027-2032) Table 36. Global Lisdexamfetamine Dimesylate Generics Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Lisdexamfetamine Dimesylate Generics Revenue by Application (2021-2026) & (K Units) Table 38. Global Lisdexamfetamine Dimesylate Generics Revenue by Application (2027-2032) & (K Units) Table 39. Global Lisdexamfetamine Dimesylate Generics Revenue Market Share by Application (2021-2026) Table 40. Global Lisdexamfetamine Dimesylate Generics Revenue Market Share by Application (2027-2032) Table 41. Global Lisdexamfetamine Dimesylate Generics Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Lisdexamfetamine Dimesylate Generics Sales by Region (2021-2026) & (K Units) Table 43. Global Lisdexamfetamine Dimesylate Generics Sales Market Share by Region (2021-2026) Table 44. Global Lisdexamfetamine Dimesylate Generics Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Lisdexamfetamine Dimesylate Generics Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Lisdexamfetamine Dimesylate Generics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Lisdexamfetamine Dimesylate Generics Sales by Country (2021-2026) & (K Units) Table 48. North America Lisdexamfetamine Dimesylate Generics Sales by Country (2027-2032) & (K Units) Table 49. Europe Lisdexamfetamine Dimesylate Generics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Lisdexamfetamine Dimesylate Generics Sales by Country (2021-2026) & (K Units) Table 51. Europe Lisdexamfetamine Dimesylate Generics Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Lisdexamfetamine Dimesylate Generics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Lisdexamfetamine Dimesylate Generics Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Lisdexamfetamine Dimesylate Generics Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Lisdexamfetamine Dimesylate Generics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Lisdexamfetamine Dimesylate Generics Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Lisdexamfetamine Dimesylate Generics Sales by Country (2027-2032) & (K Units) Table 58. Global Lisdexamfetamine Dimesylate Generics Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Lisdexamfetamine Dimesylate Generics Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Lisdexamfetamine Dimesylate Generics Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Lisdexamfetamine Dimesylate Generics Revenue Market Share by Region (2021-2026) Table 62. Global Lisdexamfetamine Dimesylate Generics Revenue Market Share by Region (2027-2032) Table 63. Zhejiang Huahai Pharmaceutical Company Information Table 64. Zhejiang Huahai Pharmaceutical Business Overview Table 65. Zhejiang Huahai Pharmaceutical Lisdexamfetamine Dimesylate Generics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Zhejiang Huahai Pharmaceutical Lisdexamfetamine Dimesylate Generics Product Portfolio Table 67. Zhejiang Huahai Pharmaceutical Recent Development Table 68. Teva Pharmaceutical Company Information Table 69. Teva Pharmaceutical Business Overview Table 70. Teva Pharmaceutical Lisdexamfetamine Dimesylate Generics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Teva Pharmaceutical Lisdexamfetamine Dimesylate Generics Product Portfolio Table 72. Teva Pharmaceutical Recent Development Table 73. Sandoz Company Information Table 74. Sandoz Business Overview Table 75. Sandoz Lisdexamfetamine Dimesylate Generics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Sandoz Lisdexamfetamine Dimesylate Generics Product Portfolio Table 77. Sandoz Recent Development Table 78. Mylan Company Information Table 79. Mylan Business Overview Table 80. Mylan Lisdexamfetamine Dimesylate Generics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Mylan Lisdexamfetamine Dimesylate Generics Product Portfolio Table 82. Mylan Recent Development Table 83. Sun Pharmaceutical Industries Ltd Company Information Table 84. Sun Pharmaceutical Industries Ltd Business Overview Table 85. Sun Pharmaceutical Industries Ltd Lisdexamfetamine Dimesylate Generics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Sun Pharmaceutical Industries Ltd Lisdexamfetamine Dimesylate Generics Product Portfolio Table 87. Sun Pharmaceutical Industries Ltd Recent Development Table 88. Mallinckrodt PLC Company Information Table 89. Mallinckrodt PLC Business Overview Table 90. Mallinckrodt PLC Lisdexamfetamine Dimesylate Generics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Mallinckrodt PLC Lisdexamfetamine Dimesylate Generics Product Portfolio Table 92. Mallinckrodt PLC Recent Development Table 93. Lannett Company Information Table 94. Lannett Business Overview Table 95. Lannett Lisdexamfetamine Dimesylate Generics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Lannett Lisdexamfetamine Dimesylate Generics Product Portfolio Table 97. Lannett Recent Development Table 98. Hikma Pharmaceuticals Company Information Table 99. Hikma Pharmaceuticals Business Overview Table 100. Hikma Pharmaceuticals Lisdexamfetamine Dimesylate Generics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Hikma Pharmaceuticals Lisdexamfetamine Dimesylate Generics Product Portfolio Table 102. Hikma Pharmaceuticals Recent Development Table 103. Ascent Pharmaceuticals Company Information Table 104. Ascent Pharmaceuticals Business Overview Table 105. Ascent Pharmaceuticals Lisdexamfetamine Dimesylate Generics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Ascent Pharmaceuticals Lisdexamfetamine Dimesylate Generics Product Portfolio Table 107. Ascent Pharmaceuticals Recent Development Table 108. Apotex Company Information Table 109. Apotex Business Overview Table 110. Apotex Lisdexamfetamine Dimesylate Generics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Apotex Lisdexamfetamine Dimesylate Generics Product Portfolio Table 112. Apotex Recent Development Table 113. Amneal Pharmaceuticals Company Information Table 114. Amneal Pharmaceuticals Business Overview Table 115. Amneal Pharmaceuticals Lisdexamfetamine Dimesylate Generics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Amneal Pharmaceuticals Lisdexamfetamine Dimesylate Generics Product Portfolio Table 117. Amneal Pharmaceuticals Recent Development Table 118. Alkem Laboratories Company Information Table 119. Alkem Laboratories Business Overview Table 120. Alkem Laboratories Lisdexamfetamine Dimesylate Generics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Alkem Laboratories Lisdexamfetamine Dimesylate Generics Product Portfolio Table 122. Alkem Laboratories Recent Development Table 123. Key Raw Materials Table 124. Raw Materials Key Suppliers Table 125. Lisdexamfetamine Dimesylate Generics Distributors List Table 126. Lisdexamfetamine Dimesylate Generics Customers List Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Lisdexamfetamine Dimesylate Generics Product Image Figure 2. Global Lisdexamfetamine Dimesylate Generics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lisdexamfetamine Dimesylate Generics Market Size (2021-2032) & (US$ Million) Figure 4. Global Lisdexamfetamine Dimesylate Generics Sales (2021-2032) & (K Units) Figure 5. Global Lisdexamfetamine Dimesylate Generics Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Lisdexamfetamine Dimesylate Generics Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Capsules Image Figure 9. Chewable Tablets Image Figure 10. Global Lisdexamfetamine Dimesylate Generics Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Lisdexamfetamine Dimesylate Generics Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Lisdexamfetamine Dimesylate Generics Sales Market Share by Type (2021-2032) Figure 13. Global Lisdexamfetamine Dimesylate Generics Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Lisdexamfetamine Dimesylate Generics Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Lisdexamfetamine Dimesylate Generics Revenue Market Share by Type (2021-2032) Figure 16. Attention Deficit Hyperactivity Disorder(ADHD) Image Figure 17. Bulimia Image Figure 18. Other Image Figure 19. Global Lisdexamfetamine Dimesylate Generics Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Lisdexamfetamine Dimesylate Generics Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Lisdexamfetamine Dimesylate Generics Sales Market Share by Application (2021-2032) Figure 22. Global Lisdexamfetamine Dimesylate Generics Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Lisdexamfetamine Dimesylate Generics Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Lisdexamfetamine Dimesylate Generics Revenue Market Share by Application (2021-2032) Figure 25. North America Lisdexamfetamine Dimesylate Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Lisdexamfetamine Dimesylate Generics Sales Market Share by Country (2021-2032) Figure 27. U.S. Lisdexamfetamine Dimesylate Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Lisdexamfetamine Dimesylate Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Lisdexamfetamine Dimesylate Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Lisdexamfetamine Dimesylate Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Lisdexamfetamine Dimesylate Generics Sales Market Share by Country (2021-2032) Figure 32. Germany Lisdexamfetamine Dimesylate Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Lisdexamfetamine Dimesylate Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Lisdexamfetamine Dimesylate Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Lisdexamfetamine Dimesylate Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Lisdexamfetamine Dimesylate Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Lisdexamfetamine Dimesylate Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Lisdexamfetamine Dimesylate Generics Sales Market Share by Country (2021-2032) Figure 39. China Lisdexamfetamine Dimesylate Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Lisdexamfetamine Dimesylate Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Lisdexamfetamine Dimesylate Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Lisdexamfetamine Dimesylate Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Lisdexamfetamine Dimesylate Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Lisdexamfetamine Dimesylate Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Lisdexamfetamine Dimesylate Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Lisdexamfetamine Dimesylate Generics Sales Market Share by Country (2021-2032) Figure 47. Brazil Lisdexamfetamine Dimesylate Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Lisdexamfetamine Dimesylate Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Lisdexamfetamine Dimesylate Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Lisdexamfetamine Dimesylate Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Lisdexamfetamine Dimesylate Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Lisdexamfetamine Dimesylate Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Lisdexamfetamine Dimesylate Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Lisdexamfetamine Dimesylate Generics Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Lisdexamfetamine Dimesylate Generics Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Lisdexamfetamine Dimesylate Generics Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Lisdexamfetamine Dimesylate Generics Revenue (2021-2032) & (US$ Million) Figure 58. North America Lisdexamfetamine Dimesylate Generics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Lisdexamfetamine Dimesylate Generics Revenue (2021-2032) & (US$ Million) Figure 60. Europe Lisdexamfetamine Dimesylate Generics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Lisdexamfetamine Dimesylate Generics Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Lisdexamfetamine Dimesylate Generics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Lisdexamfetamine Dimesylate Generics Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Lisdexamfetamine Dimesylate Generics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Lisdexamfetamine Dimesylate Generics Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Lisdexamfetamine Dimesylate Generics Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Capsules
  • Chewable Tablets
Applications
  • Attention Deficit Hyperactivity Disorder(ADHD)
  • Bulimia
  • Other
Companies covered
  • Zhejiang Huahai Pharmaceutical
  • Teva Pharmaceutical
  • Sandoz
  • Mylan
  • Sun Pharmaceutical Industries Ltd
  • Mallinckrodt PLC
  • Lannett
  • Hikma Pharmaceuticals
  • Ascent Pharmaceuticals
  • Apotex
  • Amneal Pharmaceuticals
  • Alkem Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Lisdexamfetamine Dimesylate Generics Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Lisdexamfetamine Dimesylate Generics Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Lisdexamfetamine Dimesylate Generics Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Lisdexamfetamine Dimesylate Generics Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Lisdexamfetamine Dimesylate Generics Market Dynamics
  1. 2.1 Lisdexamfetamine Dimesylate Generics Industry Trends
  2. 2.2 Lisdexamfetamine Dimesylate Generics Industry Drivers
  3. 2.3 Lisdexamfetamine Dimesylate Generics Industry Opportunities and Challenges
  4. 2.4 Lisdexamfetamine Dimesylate Generics Industry Restraints
3 Lisdexamfetamine Dimesylate Generics Market by Manufacturers
  1. 3.1 Global Lisdexamfetamine Dimesylate Generics Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Lisdexamfetamine Dimesylate Generics Sales by Manufacturers (2021-2026)
  3. 3.3 Global Lisdexamfetamine Dimesylate Generics Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Lisdexamfetamine Dimesylate Generics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Lisdexamfetamine Dimesylate Generics Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Lisdexamfetamine Dimesylate Generics Manufacturers, Product Type & Application
  7. 3.7 Global Lisdexamfetamine Dimesylate Generics Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Lisdexamfetamine Dimesylate Generics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Lisdexamfetamine Dimesylate Generics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Lisdexamfetamine Dimesylate Generics Tier 1, Tier 2, and Tier 3
4 Lisdexamfetamine Dimesylate Generics Market by Type
  1. 4.1 Lisdexamfetamine Dimesylate Generics Type Introduction
  2. 4.1.1 Capsules
  3. 4.1.2 Chewable Tablets
  4. 4.2 Global Lisdexamfetamine Dimesylate Generics Sales by Type
  5. 4.2.1 Global Lisdexamfetamine Dimesylate Generics Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Lisdexamfetamine Dimesylate Generics Sales by Type (2021-2032)
  7. 4.2.3 Global Lisdexamfetamine Dimesylate Generics Sales Market Share by Type (2021-2032)
  8. 4.3 Global Lisdexamfetamine Dimesylate Generics Revenue by Type
  9. 4.3.1 Global Lisdexamfetamine Dimesylate Generics Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Lisdexamfetamine Dimesylate Generics Revenue by Type (2021-2032)
  11. 4.3.3 Global Lisdexamfetamine Dimesylate Generics Revenue Market Share by Type (2021-2032)
5 Lisdexamfetamine Dimesylate Generics Market by Application
  1. 5.1 Lisdexamfetamine Dimesylate Generics Application Introduction
  2. 5.1.1 Attention Deficit Hyperactivity Disorder(ADHD)
  3. 5.1.2 Bulimia
  4. 5.1.3 Other
  5. 5.2 Global Lisdexamfetamine Dimesylate Generics Sales by Application
  6. 5.2.1 Global Lisdexamfetamine Dimesylate Generics Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Lisdexamfetamine Dimesylate Generics Sales by Application (2021-2032)
  8. 5.2.3 Global Lisdexamfetamine Dimesylate Generics Sales Market Share by Application (2021-2032)
  9. 5.3 Global Lisdexamfetamine Dimesylate Generics Revenue by Application
  10. 5.3.1 Global Lisdexamfetamine Dimesylate Generics Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Lisdexamfetamine Dimesylate Generics Revenue by Application (2021-2032)
  12. 5.3.3 Global Lisdexamfetamine Dimesylate Generics Revenue Market Share by Application (2021-2032)
6 Global Lisdexamfetamine Dimesylate Generics Sales by Region
  1. 6.1 Global Lisdexamfetamine Dimesylate Generics Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Lisdexamfetamine Dimesylate Generics Sales by Region (2021-2032)
  3. 6.2.1 Global Lisdexamfetamine Dimesylate Generics Sales by Region (2021-2026)
  4. 6.2.2 Global Lisdexamfetamine Dimesylate Generics Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Lisdexamfetamine Dimesylate Generics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Lisdexamfetamine Dimesylate Generics Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Lisdexamfetamine Dimesylate Generics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Lisdexamfetamine Dimesylate Generics Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Lisdexamfetamine Dimesylate Generics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Lisdexamfetamine Dimesylate Generics Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Lisdexamfetamine Dimesylate Generics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Lisdexamfetamine Dimesylate Generics Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Lisdexamfetamine Dimesylate Generics Revenue by Region
  1. 7.1 Global Lisdexamfetamine Dimesylate Generics Revenue by Region
  2. 7.1.1 Global Lisdexamfetamine Dimesylate Generics Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Lisdexamfetamine Dimesylate Generics Revenue by Region (2021-2026)
  4. 7.1.3 Global Lisdexamfetamine Dimesylate Generics Revenue by Region (2027-2032)
  5. 7.1.4 Global Lisdexamfetamine Dimesylate Generics Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Lisdexamfetamine Dimesylate Generics Revenue (2021-2032)
  8. 7.2.2 North America Lisdexamfetamine Dimesylate Generics Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Lisdexamfetamine Dimesylate Generics Revenue (2021-2032)
  11. 7.3.2 Europe Lisdexamfetamine Dimesylate Generics Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Lisdexamfetamine Dimesylate Generics Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Lisdexamfetamine Dimesylate Generics Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Lisdexamfetamine Dimesylate Generics Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Lisdexamfetamine Dimesylate Generics Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhejiang Huahai Pharmaceutical
  2. 8.1.1 Zhejiang Huahai Pharmaceutical Company Information
  3. 8.1.2 Zhejiang Huahai Pharmaceutical Business Overview
  4. 8.1.3 Zhejiang Huahai Pharmaceutical Lisdexamfetamine Dimesylate Generics Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zhejiang Huahai Pharmaceutical Lisdexamfetamine Dimesylate Generics Product Portfolio
  6. 8.1.5 Zhejiang Huahai Pharmaceutical Recent Developments
  7. 8.2 Teva Pharmaceutical
  8. 8.2.1 Teva Pharmaceutical Company Information
  9. 8.2.2 Teva Pharmaceutical Business Overview
  10. 8.2.3 Teva Pharmaceutical Lisdexamfetamine Dimesylate Generics Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Teva Pharmaceutical Lisdexamfetamine Dimesylate Generics Product Portfolio
  12. 8.2.5 Teva Pharmaceutical Recent Developments
  13. 8.3 Sandoz
  14. 8.3.1 Sandoz Company Information
  15. 8.3.2 Sandoz Business Overview
  16. 8.3.3 Sandoz Lisdexamfetamine Dimesylate Generics Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sandoz Lisdexamfetamine Dimesylate Generics Product Portfolio
  18. 8.3.5 Sandoz Recent Developments
  19. 8.4 Mylan
  20. 8.4.1 Mylan Company Information
  21. 8.4.2 Mylan Business Overview
  22. 8.4.3 Mylan Lisdexamfetamine Dimesylate Generics Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Mylan Lisdexamfetamine Dimesylate Generics Product Portfolio
  24. 8.4.5 Mylan Recent Developments
  25. 8.5 Sun Pharmaceutical Industries Ltd
  26. 8.5.1 Sun Pharmaceutical Industries Ltd Company Information
  27. 8.5.2 Sun Pharmaceutical Industries Ltd Business Overview
  28. 8.5.3 Sun Pharmaceutical Industries Ltd Lisdexamfetamine Dimesylate Generics Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sun Pharmaceutical Industries Ltd Lisdexamfetamine Dimesylate Generics Product Portfolio
  30. 8.5.5 Sun Pharmaceutical Industries Ltd Recent Developments
  31. 8.6 Mallinckrodt PLC
  32. 8.6.1 Mallinckrodt PLC Company Information
  33. 8.6.2 Mallinckrodt PLC Business Overview
  34. 8.6.3 Mallinckrodt PLC Lisdexamfetamine Dimesylate Generics Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Mallinckrodt PLC Lisdexamfetamine Dimesylate Generics Product Portfolio
  36. 8.6.5 Mallinckrodt PLC Recent Developments
  37. 8.7 Lannett
  38. 8.7.1 Lannett Company Information
  39. 8.7.2 Lannett Business Overview
  40. 8.7.3 Lannett Lisdexamfetamine Dimesylate Generics Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Lannett Lisdexamfetamine Dimesylate Generics Product Portfolio
  42. 8.7.5 Lannett Recent Developments
  43. 8.8 Hikma Pharmaceuticals
  44. 8.8.1 Hikma Pharmaceuticals Company Information
  45. 8.8.2 Hikma Pharmaceuticals Business Overview
  46. 8.8.3 Hikma Pharmaceuticals Lisdexamfetamine Dimesylate Generics Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Hikma Pharmaceuticals Lisdexamfetamine Dimesylate Generics Product Portfolio
  48. 8.8.5 Hikma Pharmaceuticals Recent Developments
  49. 8.9 Ascent Pharmaceuticals
  50. 8.9.1 Ascent Pharmaceuticals Company Information
  51. 8.9.2 Ascent Pharmaceuticals Business Overview
  52. 8.9.3 Ascent Pharmaceuticals Lisdexamfetamine Dimesylate Generics Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Ascent Pharmaceuticals Lisdexamfetamine Dimesylate Generics Product Portfolio
  54. 8.9.5 Ascent Pharmaceuticals Recent Developments
  55. 8.10 Apotex
  56. 8.10.1 Apotex Company Information
  57. 8.10.2 Apotex Business Overview
  58. 8.10.3 Apotex Lisdexamfetamine Dimesylate Generics Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Apotex Lisdexamfetamine Dimesylate Generics Product Portfolio
  60. 8.10.5 Apotex Recent Developments
  61. 8.11 Amneal Pharmaceuticals
  62. 8.11.1 Amneal Pharmaceuticals Company Information
  63. 8.11.2 Amneal Pharmaceuticals Business Overview
  64. 8.11.3 Amneal Pharmaceuticals Lisdexamfetamine Dimesylate Generics Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Amneal Pharmaceuticals Lisdexamfetamine Dimesylate Generics Product Portfolio
  66. 8.11.5 Amneal Pharmaceuticals Recent Developments
  67. 8.12 Alkem Laboratories
  68. 8.12.1 Alkem Laboratories Company Information
  69. 8.12.2 Alkem Laboratories Business Overview
  70. 8.12.3 Alkem Laboratories Lisdexamfetamine Dimesylate Generics Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Alkem Laboratories Lisdexamfetamine Dimesylate Generics Product Portfolio
  72. 8.12.5 Alkem Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Lisdexamfetamine Dimesylate Generics Value Chain Analysis
  2. 9.1.1 Lisdexamfetamine Dimesylate Generics Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Lisdexamfetamine Dimesylate Generics Production Mode & Process
  6. 9.2 Lisdexamfetamine Dimesylate Generics Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Lisdexamfetamine Dimesylate Generics Distributors
  9. 9.2.3 Lisdexamfetamine Dimesylate Generics Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst